Voyageur Pharmaceuticals Ltd.’s (VYYRF) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Voyageur Pharmaceuticals Ltd. is a Buy.

Voyageur Pharmaceuticals Ltd.’s (VYYRF) 20-Day exponential moving average is 0.07, while Voyageur Pharmaceuticals Ltd.’s (VYYRF) share price is <$0.1, making it a Buy.

Voyageur Pharmaceuticals Ltd.’s (VYYRF) 50-Day exponential moving average is 0.06, while Voyageur Pharmaceuticals Ltd.’s (VYYRF) share price is <$0.1, making it a Buy.

Advanced Chart >

Voyageur Pharmaceuticals (VYYRF) Pivot Points

Jan 15, 2025, 07:57 AM

Classic

0.07

0.08

0.09

Fibonacci

0.07

0.08

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Voyageur Pharmaceuticals (VYYRF) Moving Averages

Jan 15, 2025, 07:57 AM

MA5

0.08Buy

MA10

0.08Buy

MA20

0.07Buy

MA50

0.06Buy

MA100

0.06Buy

MA200

0.06Buy

Voyageur Pharmaceuticals Ltd.’s (VYYRF) 10-Day exponential moving average is 0.08, while Voyageur Pharmaceuticals Ltd.’s (VYYRF) share price is <$0.1, making it a Buy.

Voyageur Pharmaceuticals Ltd.’s (VYYRF) 100-Day exponential moving average is 0.06, while Voyageur Pharmaceuticals Ltd.’s (VYYRF) share price is <$0.1, making it a Buy.

Voyageur Pharmaceuticals Ltd.’s (VYYRF) stock price is <$0.1 and Voyageur Pharmaceuticals Ltd.’s (VYYRF) 50-day simple moving average is 0.06, creating a Buy signal.

Voyageur Pharmaceuticals Ltd.’s (VYYRF) stock price is <$0.1 and Voyageur Pharmaceuticals Ltd.’s (VYYRF) 100-day simple moving average is 0.06, creating a Buy signal.

Voyageur Pharmaceuticals Ltd.’s (VYYRF) stock price is <$0.1 and Voyageur Pharmaceuticals Ltd.’s (VYYRF) 200-day simple moving average is 0.06, creating a Buy signal.

Voyageur Pharmaceuticals (VYYRF) Technical Indicators

Jan 15, 2025, 07:57 AM

RSI (14)

68.63

Neutral

STOCH (9,6)

50.88

Neutral

STOCHRSI (14)

69.10

Neutral

MACD (12,26)

<0.01

Buy

ADX (14)

49.34

Neutral

Williams %R

-31.58

Buy

CCI (14)

23.86

Neutral

ATR (14)

<0.01

Ultimate Oscillator

49.45

Neutral

ROC

60.00

Buy

Voyageur Pharmaceuticals Ltd.’s (VYYRF) Relative Strength Index (RSI) is 68.63, creating a Neutral signal.

Voyageur Pharmaceuticals Ltd.’s (VYYRF) Trend Strength Indicator (ADX) is 49.34, creating a Neutral signal.

Voyageur Pharmaceuticals Ltd.’s (VYYRF) Commodity Channel Index (CCI) is 23.86, creating a Neutral signal.

Voyageur Pharmaceuticals Ltd.’s (VYYRF) Price Rate of Change (ROC) is 60.00, creating a Buy signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is VYYRF a Buy, Hold, or Sell?

Based on VYYRF’s technical indicators, VYYRF is a Strong Buy.

What is VYYRF’s RSI (14)?

VYYRF’s RSI (14) is 68.63, which suggests VYYRF is a Neutral.

What is VYYRF’s MACD?

VYYRF’s MACD is <0.01, which suggests VYYRF is a Buy.

What is VYYRF’s 5-day moving average?

VYYRF’s 5-day moving average is 0.08, which suggests VYYRF is a Buy.

What is VYYRF’s 20-day moving average?

VYYRF 20-day moving average is 0.07, which suggests VYYRF is a Buy.

What is VYYRF’s 50-day moving average?

VYYRF’s 50-day moving average is 0.06, which suggests VYYRF is a Buy.

What is VYYRF’s 200-day moving average?

VYYRF’s 200-day moving average is 0.06, which suggests VYYRF is a Buy.

What is VYYRF’s Williams % R (14)?

VYYRF’s Williams % R (14) is -31.58, which suggests VYYRF is a Buy.

What is VYYRF’s CCI (14)?

VYYRF’s CCI (14) is 23.86, which suggests VYYRF is a Neutral.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing